In a major development for pharmaceutical and transplant medicine, the Sirolimus Market is surging ahead, driven by expanding clinical applications, rising organ transplant rates, and increased research into rare diseases and autoimmune conditions. Valued for its potent immunosuppressive and antiproliferative properties, sirolimus—also known as rapamycin—is becoming a...